Senescent CD8+ T cells impair CAR T therapy by reducing cell growth, migration, and tumor killing, with gene signatures ...
In recognition of World Hand Hygiene Day, the National Foundation for Infectious Diseases (NFID) is reminding everyone to take a simple but powerful step to help protect their health: wash their ...
Successfully met primary endpoint of HiSCR75 for both doses studied, demonstrating response rates of 42.2% for 150 mg dose (p=0.018) and 42.9% ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today ...
Teen therapy equips adolescents with CBT, mindfulness, and communication skills to manage stress and anxiety and build ...
Enrollment underway in SOL-X long-term extension trial in wet AMD for subjects completing two-year follow-up in SOL-1 or SOL-R Announced positive Phase 3 SOL-1 results in February 2026, first ever ...
Gene syntax alters DNA supercoiling to amplify or suppress nearby genes. This could improve the effectiveness of gene ...
Net loss attributable to AdaptHealth Corp. was $16.0 million compared to net loss of $7.2 million. Adjusted EBITDA was $121.2 million compared to $127.9 million, a decrease of 5.3%. Cash flow from ...
Texas is helping shape the future of psychedelic therapies. Here's how they work and what access could look like.
Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results